Date of Graduation

12-2019

Document Type

Thesis

Degree Name

Master of Science in Cell & Molecular Biology (MS)

Degree Level

Graduate

Department

Cell & Molecular Biology

Advisor/Mentor

Beitle, Robert R. Jr.

Committee Member

Sakon, Joshua

Second Committee Member

Hestekin, Christa N.

Keywords

Collagen binding domains; E. coli hosts; Fed-batch; Fibroblast Growth Factor; Fusion protein

Abstract

Delivering effective and non-toxic doses of bioactive materials that can aid in activating tissue regeneration to wounded tissue has proven to be an enormous challenge. This study was designed to produce a potential therapeutic recombinant protein by fusing two collagen binding domains to basic fibroblast growth factors (bFGF) through a collagenase cleavage site linker, so it can release the bFGF in a wound site by the action of this enzyme. The novel fusion protein was expressed in Escherichia coli BL-21 (E. coli) using traditional flask shaker and fed-batch cultivation. Cell lysate was purified by FPLC using Immobilized metal affinity chromatography and heparin heparin-affinity chromatography. Results showed that the desired fusion protein was expressed, but different truncated products were also evident including a protease within E.coil may indeed recognize the designed collagenase cleavage site sequence.

Share

COinS